Simplex Trading, LLC Olema Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$8.73 - $13.99 $12,379 - $19,837	-1,418 Reduced 65.83%	736 $7,000
Q1 2024 Apr 25, 2024	SELL	$10.95 - $16.62 $180,642 - $274,180	-16,497 Reduced 88.45%	2,154 $24,000
Q4 2023 Feb 02, 2024	BUY	$10.53 - $17.14 $196,395 - $319,678	18,651 New	18,651 $261,000
Q2 2023 Aug 04, 2023	BUY	$3.22 - $9.65 $3,651 - $10,943	1,134 New	1,134 $10,000
Q3 2022 Nov 04, 2022	BUY	$2.72 - $5.88 $394 - $852	145 Added 245.76%	204 $0
Q2 2022 Aug 03, 2022	SELL	$2.04 - $4.61 $597 - $1,350	-293 Reduced 83.24%	59 $0
Q1 2022 May 02, 2022	SELL	$3.89 - $9.43 $15,489 - $37,550	-3,982 Reduced 91.88%	352 $1,000
Q4 2021 Feb 23, 2022	BUY	$8.75 - $30.71 $37,922 - $133,097	4,334 New	4,334 $40,000

143

58.8M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $258M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.